165 related articles for article (PubMed ID: 17132416)
1. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries.
Ackroyd R; Mouiel J; Chevallier JM; Daoud F
Obes Surg; 2006 Nov; 16(11):1488-503. PubMed ID: 17132416
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries(II).
Anselmino M; Bammer T; Fernández Cebrián JM; Daoud F; Romagnoli G; Torres A
Obes Surg; 2009 Nov; 19(11):1542-9. PubMed ID: 19756896
[TBL] [Abstract][Full Text] [Related]
3. [Medicoeconomic evaluation of the treatment of morbid obesity by Swedish adjustable gastric banding (SAGB)].
Chevallier JM; Daoud F; Szwarcensztein K; Volcot MF; Rupprecht MF
Ann Chir; 2006 Jan; 131(1):12-21. PubMed ID: 16364230
[TBL] [Abstract][Full Text] [Related]
4. Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses.
McGlone ER; Carey I; Veličković V; Chana P; Mahawar K; Batterham RL; Hopkins J; Walton P; Kinsman R; Byrne J; Somers S; Kerrigan D; Menon V; Borg C; Ahmed A; Sgromo B; Cheruvu C; Bano G; Leonard C; Thom H; le Roux CW; Reddy M; Welbourn R; Small P; Khan OA
PLoS Med; 2020 Dec; 17(12):e1003228. PubMed ID: 33285553
[TBL] [Abstract][Full Text] [Related]
5. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study.
Carrington M; Stewart S
Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of bariatric surgery.
Fang J
Am J Gastroenterol; 2003 Sep; 98(9):2097-8. PubMed ID: 14499794
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK.
Pollock RF; Muduma G; Valentine WJ
Diabetes Obes Metab; 2013 Feb; 15(2):121-9. PubMed ID: 22882321
[TBL] [Abstract][Full Text] [Related]
8. Cost-Utility of Gastric Bypass Surgery Compared to Clinical Treatment for Severely Obese With and Without Diabetes in the Perspective of the Brazilian Public Health System.
Assumpção RP; Bahia LR; da Rosa MQM; Correia MG; da Silva EN; Zubiaurre PR; Mottin CC; Vianna DA
Obes Surg; 2019 Oct; 29(10):3202-3211. PubMed ID: 31214966
[TBL] [Abstract][Full Text] [Related]
9. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic adjustable gastric banding vs standard medical management in obese patients with type 2 diabetes: a budget impact analysis in the UK.
Pollock RF; Chilcott J; Muduma G; Valentine WJ
J Med Econ; 2013; 16(2):249-59. PubMed ID: 23163313
[TBL] [Abstract][Full Text] [Related]
12. [Obesity and health economics. Review and status].
Pedersen KM; Worre-Jensen AL
Ugeskr Laeger; 2006 Jan; 168(2):196-201. PubMed ID: 16403351
[TBL] [Abstract][Full Text] [Related]
13. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
Brancatisano A; Wahlroos S; Matthews S; Brancatisano R
Surg Obes Relat Dis; 2008; 4(3):423-9. PubMed ID: 18226973
[TBL] [Abstract][Full Text] [Related]
14. Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort.
Tu Y; Wang L; Wei L; Xu Y; Han X; Han J; Yu H; Zheng C; Bao Y; Jia W
Obes Surg; 2019 Dec; 29(12):3978-3986. PubMed ID: 31338737
[TBL] [Abstract][Full Text] [Related]
15. A payer's perspective on the cost effectiveness of gastric bypass surgery.
Gandjour A
Am J Manag Care; 2009 Nov; 15(11):826-8; author reply 828-30. PubMed ID: 19895187
[No Abstract] [Full Text] [Related]
16. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial.
Angrisani L; Lorenzo M; Borrelli V
Surg Obes Relat Dis; 2007; 3(2):127-32; discussion 132-3. PubMed ID: 17331805
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
[TBL] [Abstract][Full Text] [Related]
18. Adjustable gastric banding, sleeve gastrectomy or gastric bypass. Can evidence-based medicine help us to choose?
Caiazzo R; Pattou F
J Visc Surg; 2013 Apr; 150(2):85-95. PubMed ID: 23623562
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
20. Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model.
Faria GR; Preto JR; Costa-Maia J
Obes Surg; 2013 Apr; 23(4):460-6. PubMed ID: 23341033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
